The Journal of Neuropsychiatry and Clinical Neurosciences
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
J Neuropsychiatry Clin Neurosci 18:178-185, May 2006
doi: 10.1176/appi.neuropsych.18.2.178
© 2006 American Neuropsychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Chen, X.
* Articles by Schultz, S. K.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Chen, X.
* Articles by Schultz, S. K.
Related Collections
* Cognition

Donepezil Effects on Cerebral Blood Flow in Older Adults With Mild Cognitive Deficits

Xiying Chen, Ph.D., Vincent A. Magnotta, Ph.D., Kevin Duff, Ph.D., Laura L. Boles Ponto, Ph.D. and Susan K. Schultz, M.D.

Received January 24, 2005; revised April 24, 2005; accepted May 16, 2005. From the Roy J. and Lucille A. Carver College of Medicine, Departments of Radiology and Psychiatry, Iowa City, Iowa. Address correspondence to Dr. Schultz, Psychiatry Research, 2-207 Medical Education Building, The Roy J. and Lucille A. Carver College of Medicine, 500 Newton Rd., Iowa City, IA 52242-1000; susan-schultz{at}uiowa.edu (E-mail).

Cerebral blood flow (CBF) was assessed during a verbal recall task using [15O]water positron emission tomography (PET) in older adults with mild cognitive deficits participating in a placebo-controlled donepezil trial. The placebo group demonstrated reduced CBF in the left frontal and temporal regions over the 6-month period, while those receiving donepezil did not. The placebo group’s performance did not change on a list-learning task, while the donepezil group’s performance improved, despite having had lower performance at intake. These findings suggest that donepezil treatment may be associated with a relative maintenance of CBF and improved list-learning.




This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
S. Vale
Current Management of the Cognitive Dysfunction in Parkinson's Disease: How Far Have We Come?
Experimental Biology and Medicine, August 1, 2008; 233(8): 941 - 951.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2006 American Neuropsychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Neuropsychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org